K Canfell
Overview
Explore the profile of K Canfell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
So C, Cust A, Gordon L, Morton R, Canfell K, Ngo P, et al.
Skin Health Dis
. 2022 Jun;
1(3):e51.
PMID: 35663144
Background: Non-melanoma skin cancers (NMSCs) are common and consume many healthcare resources. A health utility is a single preference-based value for assessing health-related quality of life, which can be used...
2.
Vujovich-Dunn C, Wand H, Brotherton J, Gidding H, Sisnowski J, Lorch R, et al.
BMC Public Health
. 2022 Apr;
22(1):822.
PMID: 35468743
Background: In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-old males had received at least one dose of the HPV vaccine. However, considerable variation in HPV vaccination...
3.
Sisnowski J, Vujovich-Dunn C, Gidding H, Brotherton J, Wand H, Lorch R, et al.
Vaccine
. 2021 Sep;
39(41):6117-6126.
PMID: 34493408
Background: Schools are the primary setting for the delivery of adolescent HPV vaccination in Australia. Although this strategy has achieved generally high vaccination coverage, gaps persist for reasons that are...
4.
Davies-Oliveira J, Smith M, Grover S, Canfell K, Crosbie E
Clin Oncol (R Coll Radiol)
. 2021 Jul;
33(9):550-559.
PMID: 34315640
In 2020, the World Health Organization launched a major initiative to eliminate cervical cancer globally. The initiative is built around the three key pillars of human papillomavirus (HPV) vaccination, cervical...
5.
Acuti Martellucci C, Nomura S, Yoneoka D, Ueda P, Brotherton J, Canfell K, et al.
BJOG
. 2020 Aug;
128(3):532-539.
PMID: 32779381
Objective: To assess the effectiveness of an HPV vaccination programme in reducing the risk of cervical abnormalities identified at subsequent screening. Design: Retrospective cohort study using administrative health data. Setting:...
6.
Worthington J, Feletto E, Lew J, Broun K, Durkin S, Wakefield M, et al.
Public Health
. 2019 Nov;
179:90-99.
PMID: 31760206
Objectives: The Australian National Bowel Cancer Screening Program (NBCSP) offers free 2-yearly immunochemical faecal occult blood testing to individuals aged 50-74 years; national participation in 2015-2016 was 41%. In 2017,...
7.
Feletto E, Grogan P, Vassallo A, Canfell K
Climacteric
. 2019 Aug;
22(6):538-543.
PMID: 31378097
As the cancer burden increases, so too does the cost, to health systems, economies, and individuals. There is increasing interest in productivity and out-of-pocket costs for individuals and their carers,...
8.
Velentzis L, Brotherton J, Canfell K
Climacteric
. 2019 Apr;
22(6):596-602.
PMID: 31030590
Existing modalities can effectively treat high-grade cervical intraepithelial neoplasia (CIN) but around 7% of treated women will develop recurrence of CIN grade 2 or above within 2 years of treatment....
9.
Canfell K
Climacteric
. 2018 Mar;
21(3):227-234.
PMID: 29565690
Cervical screening with cytology has been the basis for substantial reductions in cervical cancer incidence and mortality in most high-income countries over the last few decades. More recently, there have...
10.
Greuter M, Lew J, Berkhof J, Canfell K, Dekker E, Meijer G, et al.
Value Health
. 2016 May;
17(7):A323.
PMID: 27200528
No abstract available.